SOURCE: Strategic Rare Earth Metals, Inc.
SNI Captures Promising Revenue Potential With Non-Biased Medical Reporting in Major Fields
NEW YORK, NY–(Marketwire – July 23, 2010) – (
The projections have been laid out conservatively and factors in a variable attrition rate. “Further,” states CEO Anthony Dibiase, “these figures were calculated with an assumption that only the lower subscription tier was selected by all members. We did this to remain conservative in our projections and even a fraction of doctors choosing to subscribe as premium members would have a significant impact on these numbers. As well, these figures are only based on subscription fees and do not include iPhone app sales, doctor2doctor social networking platform upgrades or doctor2doctor prospective ad revenue.”
SNI Execs are confident it can reach at least 10% of its target market by July 31, 2011 resulting in more than $1 million in gross revenues there. SNI target market includes professionals from all of the major fields the site currently covers: Cardiology, Gastroenterology, Hematology, Nephrology, Oncology, Primary Care, Rheumatology, Urology and Radiology. By year 3, the site expects to reach approximately $5 million in subscription fees alone. “With supplementary medical fields, increased conference attendance, additional iPhone apps and doctor2doctor revenues, we release these projections with the understanding that they are only a fraction of revenues overall for the company. Expanded projections will be released in the near future to reflect additional revenue streams,” comments Dibiase.
| 3 mos ending | 3 mos ending | 3 mos ending | 3 mos ending |
| Oct 31, 2010 | Jan 31, 2011 | Apr 30, 2011 | July 31, 2011 |
| Total Subscriptions Sold: | |||
| End of Period | |||
| 3,018 | 6,194 | 11,626 | 19,347 |
| Gross Revenue: | |||
| End of Period | |||
| $75,450 | $230,300 | $520,950 | $1,004,625 |
| 3 mos ending | 3 mos ending | 3 mos ending | 3 mos ending |
| Oct 31, 2011 | Jan 31, 2012 | Apr 30, 2012 | July 31, 2012 |
| Total Subscriptions Sold: | |||
| End of Period | |||
| 25,085 | 30,897 | 34,516 | 38,004 |
| Gross Revenue: | |||
| End of Period | |||
| $627,125 | $1,399,550 | $2,262,450 | $3,212,550 |
| 3 mos ending | 3 mos ending | 3 mos ending | 3 mos ending |
| Oct 31, 2012 | Jan 31, 2013 | Apr 30, 2013 | July 31, 2013 |
| Total Subscriptions Sold: | |||
| End of Period | |||
| 42,568 | 47,521 | 52,096 | 57,008 |
| Gross Revenue: | |||
| End of Period | |||
| $1,064,200 | $2,252,225 | $3,554,625 | $4,979,825 |
CUTTING EDGE MEDICAL MEETING NEWS EXCLUSIVELY AT Scientific News International! (www.scientificnewsroom.com) is SREH’s premiere all-in-one platform for medical conference and news information focusing on Cardiology, Gastroenterology, Hematology, Nephrology, Oncology, Primary Care, Rheumatology and Urology. The site is the web’s only online resource for medical professionals with access to the latest, cutting edge data presented at major medical meetings worldwide. Staffed by global medical writers, SNI reports the most current research and therapy findings directly. The site’s profitability is IP and subscription based without bias from any medical or pharmaceutical provider.
In the beginning, there was… Fishing, Manga, global tide reports and more! Get your iPhoneMobile2Earth (www.mobile2earth.com) app now. Choose from the iPhone King James Bible, fishing reports worldwide, Japanese e-books and comics and so much more! Get ready, as Mobile2Earth unleashes phase 1 of its iPhone app releases for mass consumption.
Safe Harbor: This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.
CONTACT:
SRE Holdings Dba Strategic Rare Earth Metals
[email protected]